Elizabeth M Mahoney

Summary

Affiliation: Saint Luke's Hospital
Country: USA

Publications

  1. ncbi Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasug
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 121:71-9. 2010
  2. ncbi One-year costs in patients with a history of or at risk for atherothrombosis in the United States
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 1:38-45. 2008
  3. ncbi Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart and Vascular Institute, Kansas City, MO, USA
    Circ Cardiovasc Qual Outcomes 3:642-51. 2010
  4. ncbi Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 2:344-53. 2009
  5. ncbi Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial
    Elizabeth M Mahoney
    Cardiovascular Research Center, Saint Luke s Mid America Heart and Vascular Institute, Kansas City, Missouri, USA
    Catheter Cardiovasc Interv 77:463-72. 2011
  6. ncbi One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry
    Kim G Smolderen
    Mid America Heart Institute of Saint Luke s Hospital, Kansas City, Missouri, USA
    Can J Cardiol 26:297-305. 2010
  7. ncbi Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    N Engl J Med 364:1016-26. 2011
  8. ncbi Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry
    Lakshmi Venkitachalam
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, School of Medicine, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 124:1028-37. 2011
  9. ncbi Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 1:107-15. 2008
  10. ncbi Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding
    Amit P Amin
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 3:358-65. 2010

Detail Information

Publications11

  1. ncbi Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasug
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 121:71-9. 2010
    ..We evaluated the cost-effectiveness of prasugrel versus clopidogrel from the perspective of the US healthcare system by using data from TRITON-TIMI 38...
  2. ncbi One-year costs in patients with a history of or at risk for atherothrombosis in the United States
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 1:38-45. 2008
    ....
  3. ncbi Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart and Vascular Institute, Kansas City, MO, USA
    Circ Cardiovasc Qual Outcomes 3:642-51. 2010
    ....
  4. ncbi Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 2:344-53. 2009
    ..Angina in patients with coronary artery disease is associated with worse quality of life; however, the relationship between angina frequency and resource utilization is unknown...
  5. ncbi Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial
    Elizabeth M Mahoney
    Cardiovascular Research Center, Saint Luke s Mid America Heart and Vascular Institute, Kansas City, Missouri, USA
    Catheter Cardiovasc Interv 77:463-72. 2011
    ..To evaluate the cost-effectiveness of carotid stenting vs. carotid endarterectomy using data from the SAPPHIRE trial...
  6. ncbi One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry
    Kim G Smolderen
    Mid America Heart Institute of Saint Luke s Hospital, Kansas City, Missouri, USA
    Can J Cardiol 26:297-305. 2010
    ....
  7. ncbi Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    N Engl J Med 364:1016-26. 2011
    ..The effect of PCI with the use of drug-eluting stents on these outcomes is unknown...
  8. ncbi Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry
    Lakshmi Venkitachalam
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, School of Medicine, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 124:1028-37. 2011
    ..Although the benefits of drug-eluting stents (DES) for reducing restenosis after percutaneous coronary intervention are well established, the impact of alternative rates of DES use on population-level outcomes is unknown...
  9. ncbi Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 1:107-15. 2008
    ..Ranolazine has been shown to reduce myocardial ischemia and symptom severity among selected patients with chronic angina. However, data regarding the effect of ranolazine on health status/quality of life (QOL) are limited...
  10. ncbi Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding
    Amit P Amin
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 3:358-65. 2010
    ....
  11. ncbi Health-related quality of life following carotid stenting versus endarterectomy: results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at HIgh Risk for Endarterectomy) trial
    Joshua M Stolker
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri, USA
    JACC Cardiovasc Interv 3:515-23. 2010
    ..This study compared health-related quality of life in patients undergoing carotid artery stenting (CAS) versus surgical endarterectomy (CEA)...